<SEC-DOCUMENT>0001213900-25-109286.txt : 20251112
<SEC-HEADER>0001213900-25-109286.hdr.sgml : 20251112
<ACCEPTANCE-DATETIME>20251112164716
ACCESSION NUMBER:		0001213900-25-109286
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251112
DATE AS OF CHANGE:		20251112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bitdeer Technologies Group
		CENTRAL INDEX KEY:			0001899123
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		ORGANIZATION NAME:           	09 Crypto Assets
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283732
		FILM NUMBER:		251473771

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		08 KALLANG AVENUE, APERIA TOWER 1, #09-0
		CITY:			SINGAPORE
		PROVINCE COUNTRY:   	U0
		BUSINESS PHONE:		65-62828220

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		08 KALLANG AVENUE, APERIA TOWER 1, #09-0
		CITY:			SINGAPORE
		PROVINCE COUNTRY:   	U0
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>ea0265279-424b5_bitdeer.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule 424(b)(5)<BR>
Registration No. 333-283732</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Amendment No. 1, dated November 12, 2025<BR>
</B>(To Prospectus Supplement dated January 3, 2025<BR>
and Prospectus dated December 18, 2024)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: center">Up to US$750,000,000</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: center">Bitdeer Technologies Group</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: center">Class A Ordinary Shares</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus supplement amendment No. 1 (this
&ldquo;amendment&rdquo;) amends the prospectus supplement, dated January 3, 2025, filed pursuant to Rule 424(b)(5) of the Securities Act
of 1933, as amended (File No. 333-283732) (the &ldquo;prospectus supplement&rdquo;). This amendment should be read in conjunction with
the prospectus supplement and the accompanying prospectus, dated December 18, 2024 (the &ldquo;prospectus&rdquo;), and is qualified by
reference thereto, except to the extent that the information herein amends or supersedes the information contained in the prospectus supplement
and the prospectus. This amendment is not complete without, and may only be delivered or utilized in connection with, the prospectus supplement
and the prospectus and any future amendments or supplements thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On January 3, 2025, we entered into an At Market
Issuance Sales Agreement (the &ldquo;sales agreement&rdquo;) with Barclays Capital Inc. (&ldquo;Barclays&rdquo;), Cantor Fitzgerald &amp;
Co. (&ldquo;Cantor&rdquo;), A.G.P./Alliance Global Partners (&ldquo;AGP&rdquo;), The Benchmark Company, LLC (&ldquo;Benchmark&rdquo;),
B. Riley Securities, Inc. (&ldquo;B. Riley Securities&rdquo;), BTIG, LLC (&ldquo;BTIG&rdquo;), Keefe, Bruyette &amp; Woods, Inc. (&ldquo;KBW&rdquo;),
Needham &amp; Company, LLC (&ldquo;Needham&rdquo;), Northland Securities, Inc. (&ldquo;Northland&rdquo;), Rosenblatt Securities Inc. (&ldquo;Rosenblatt&rdquo;),
Roth Capital Partners, LLC (&ldquo;Roth&rdquo;) and StockBlock Securities LLC (&ldquo;StockBlock,&rdquo; and each of Barclays, Cantor,
AGP, Benchmark, B. Riley Securities, BTIG, KBW, Needham, Northland, Rosenblatt, Roth and StockBlock, a &ldquo;Sales Agent&rdquo; and collectively,
the &ldquo;Sales Agents&rdquo;), relating to the sale of our Class A ordinary shares, with a par value of US$0.0000001 each (the &ldquo;Class
A ordinary shares&rdquo;), offered by the prospectus supplement and the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are filing this amendment to amend the prospectus
supplement solely to reflect a reduction in the total aggregate offering price of Class A ordinary shares we may offer and sell under
the prospectus supplement and the accompanying prospectus from US$1,000,000,000 to US$750,000,000. In accordance with the terms of the
sales agreement, under the prospectus supplement, as amended by this amendment, we may offer and sell our Class A ordinary shares having
an aggregate offering price of up to US$750,000,000 from time to time through or to the sales agents, as agent or principal. As of the
date of this amendment, we have sold Class A ordinary shares pursuant to the sales agreement for aggregate gross proceeds of US$102.2
million, which are included in the US$750,000,000 of our Class A ordinary shares we may offer and sell under the prospectus supplement
and the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Sales of our Class A ordinary shares, if any, under
the prospectus supplement, as amended by this amendment, and the accompanying prospectus, may be made in negotiated transactions, including
block trades, or transactions that are deemed to be &ldquo;at the market&rdquo; offerings as defined in&nbsp;Rule 415&nbsp;under the&nbsp;Securities
Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), including sales made by means of ordinary brokers&rsquo; transactions, including
directly on The Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;) or sales made to or through a market maker other than on an exchange at prevailing
market prices, at prices related to prevailing market prices or at negotiated prices or by any other method permitted by law. Subject
to the terms of the sales agreement, the Sales Agents are not required to sell any specific amount, but will act as our Sales Agents using
commercially reasonable efforts consistent with their normal trading and sales practices. There is no arrangement for funds to be received
in an escrow, trust or similar arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The designated Sales Agent will be entitled to
compensation at a commission rate of up to 3.0% of the gross sales price of any Class A ordinary shares sold under the sales agreement.
In connection with the sale of Class A ordinary shares on our behalf, each Sales Agent will be deemed to be an &ldquo;underwriter&rdquo;
within the meaning of the&nbsp;Securities Act&nbsp;and the compensation of the Sales Agents will be deemed to be underwriting commissions
or discounts. We have also agreed to provide indemnification and contribution to the Sales Agents with respect to certain liabilities,
including civil liabilities under the&nbsp;Securities Act. See &ldquo;Plan of Distribution&rdquo; beginning on page S-13&nbsp;of the prospectus
supplement for additional information regarding the compensation to be paid to the Sales Agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Class A ordinary shares are currently listed
on Nasdaq under the symbol &ldquo;BTDR.&rdquo; On November 11, 2025, the last reported sales price of our Class A ordinary shares was
US$15.02 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Investing in our securities involves a high
degree of risk. See the &lsquo;&lsquo;<I>Risk Factors</I>&rdquo; section beginning on page S-8 of the prospectus supplement and any risk
factors in our U.S. Securities and Exchange Commission filings that are incorporated by reference in the prospectus supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>None of the U.S. Securities and Exchange Commission
or any state securities commission has approved or disapproved of the securities or determined if the prospectus supplement or the accompanying
prospectus is accurate or adequate. Any representation to the contrary is a criminal offense. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font-size: 12pt">
    <TD COLSPAN="3" STYLE="font-size: 12pt; vertical-align: top; text-align: center"><FONT STYLE="font-size: 12pt"><B>Barclays</B></FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 12pt"><B>&ensp;</B></FONT></TD>
    <TD STYLE="font-size: 12pt; vertical-align: top; text-align: center"><FONT STYLE="font-size: 12pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 12pt; text-align: center"><FONT STYLE="font-size: 12pt"><B>&ensp;</B></FONT></TD>
    <TD COLSPAN="3" STYLE="font-size: 12pt; vertical-align: top; text-align: center"><FONT STYLE="font-size: 12pt"><B>Cantor</B></FONT></TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 19%; text-align: center"><FONT STYLE="font-size: 10pt"><B>A.G.P.</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center"><FONT STYLE="font-size: 10pt"><B>&ensp;</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 19%; text-align: center"><FONT STYLE="font-size: 10pt"><B>The Benchmark Company</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center"><FONT STYLE="font-size: 10pt"><B>&ensp;</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 19%; text-align: center"><FONT STYLE="font-size: 10pt"><B>B. Riley Securities</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center"><FONT STYLE="font-size: 10pt"><B>&ensp;</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 19%; text-align: center"><FONT STYLE="font-size: 10pt"><B>BTIG</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center"><FONT STYLE="font-size: 10pt"><B>&ensp;</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 20%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Keefe, Bruyette &amp; Woods</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>A Stifel Company</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>Needham &amp; Company</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>&ensp;</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>Northland Capital Markets</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>&ensp;</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>Rosenblatt</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>&ensp;</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>Roth Capital Partners</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>&ensp;</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt"><B>StockBlock</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">This Amendment No. 1 to the Prospectus Supplement
is dated November 12, 2025</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  H ,X# 2(  A$! Q$!_\0
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:5!-+\J1GBG9,]@***TJ485&G);$QFX['_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
